Factors Influence Diabetic Type I Complications, Retrospective Study In Zlitan Diabetic Center
Keywords:
Diabetes complications, Diabetes mellitus, type 1, Diabetic nephropathies, Retinopathy, Neuropathy, angiopathyAbstract
Background: The aim of this study was to determine percentage of type I diabetic patients (T1DM) from total diabetic clinical visits to Zlitan Diabetic Center (ZDC) during the period between January and May 2014, and determine the incidence of long-term diabetic complications according to recorded HbA1c level and disease duration.
Methods: This was a retrospective study. Data was obtained from Zlitan Diabetic Center from Jan 2014 to May 2014. Only 91 patients out of total 1275 diabetic patients were diagnosed as T1DM. Patients were categorized first according to age of diagnosis second according to their diabetic care through HbA1c level and finally in base of disease duration then patients were categorized according to the relation between HbA1c level and disease duration and the incidences of long-term diabetic complication.
Results: About of 45.05% of patients were diagnosed with disease at age less than 18 year’s old, our sample showed in poor health diabetic care, where only 4.40% showed acceptable diabetic care (HbA1c <7) and only 21.98 at the border lines (HbA1c 7-9) while the reset of patients recorded with bad records where HbA1c recorded as more than 9. On the other hand, this sample indicated high prevalences of long-term diabetic complication, where 12.09% of patients were diagnosed with Retinopathy, moreover 17.58% of patients suffered from a Neuropathy state, while the Angiopathy state were observed only in 3.30% of patients, also 8.79% of patients were recorded with the Nephropathy complication. Finally, only three patients were diagnosed with Angiopathy state, two of them the level of HbA1c was not recorded and all of them diagnosed with this state within the first five years of diabetic diagnosis.
Conclusion: In this group of T1DM patients, the onset of disease was high at age more than 18 year’s old. The present study showed that more younger patients present to the hospital in a state of diabetic complications in early years of disease diagnosis. Efforts should be directed at improving the knowledge and skills of the primary health care personnel to be able to diagnose and refer these cases earlier.
References
Lipton, R.B., et al., Obesity at the onset of diabetes in an ethnically diverse population of children: what does it mean for epidemiologists and clinicians? Pediatrics, 2005. 115(5): p. e553-60.
Fagot-Campagna, A., et al., Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr, 2000. 136(5): p. 664-72.
Maahs, D.M., et al., Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am, 2010. 39(3): p. 481-97.
Diaz-Valencia, P.A., P. Bougneres, and A.J. Valleron, Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health, 2015. 15: p. 255.
Munoz, C., et al., Misdiagnosis and Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes: Patient and Caregiver Perspectives. Clin Diabetes, 2019. 37(3): p. 276-281.
Thomas, N.J., et al., Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes. Diabetologia, 2019. 62(7): p. 1167-1172.
Imperatore, G., et al., Prevalence and Incidence of Type 1 Diabetes Among Children and Adults in the United States and Comparison With Non-U.S. Countries, in Diabetes in America, C.C. Cowie, et al., Editors. 2018: Bethesda (MD) conflicts of interest, with the following potential exception. Dr. Zhong received support from Sanofi US as a UNC Sanofi Global Nutrition Scholar at the University of North Carolina at Chapel Hill.
Thunander, M., et al., Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract, 2008. 82(2): p. 247-55.
Rogers, M.A.M., et al., Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. BMC Med, 2017. 15(1): p. 199.
Thomas, N.J., et al., Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol, 2018. 6(2): p. 122-129.
Vigersky, R.A., Going beyond HbA1c to understand the benefits of advanced diabetes therapies. J Diabetes, 2019. 11(1): p. 23-31.
Bjerg, L., et al., Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study. Diabetologia, 2019. 62(4): p. 633-643.
Jennings, S.M., et al., Trends in hospitalisation for acute myocardial infarction in Ireland, 1997-2008. Heart, 2012. 98(17): p. 1285-9.
Schmidt, M., et al., Long-Term Survival Among Patients With Myocardial Infarction Before Age 50 Compared With the General Population: A Danish Nationwide Cohort Study. Circ Cardiovasc Qual Outcomes, 2016. 9(5): p. 523-31.
Cheung, N., P. Mitchell, and T.Y. Wong, Diabetic retinopathy. Lancet, 2010. 376(9735): p. 124-36.
Bourne, R.R., et al., Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health, 2013. 1(6): p. e339-49.
Piona, C., et al., Long-term complications of type 1 diabetes: what do we know and what do we need to understand? Minerva Pediatr (Torino), 2021. 73(6): p. 504-522.
American Diabetes, A., Diagnosis and classification of diabetes mellitus. Diabetes Care, 2009. 32 Suppl 1(Suppl 1): p. S62-7.
Green, A., et al., Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia, 2021. 64(12): p. 2741-2750.
Katte, J.C., et al., The phenotype of type 1 diabetes in sub-Saharan Africa. Front Public Health, 2023. 11: p. 1014626.
Khashebi, R.M., C.C. Patterson, and M.S. Shebani, The Incidence Trend of Type 1 Diabetes among Children and Adolescents 0-14 Years of Age in the West, South, and Tripoli Regions of Libya (2009-2018). J Clin Res Pediatr Endocrinol, 2023. 15(4): p. 356-364.
Nordwall, M., et al., Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care, 2015. 38(2): p. 308-15.
Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature, 2001. 414(6865): p. 813-20.
Currie, C.J., et al., The impact of treatment non-compliance on mortality in people with type 1 diabetes. J Diabetes Complications, 2013. 27(3): p. 219-23.
Gilbert, R.E., Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease. Diabetes, 2017. 66(4): p. 791-800
